Company / Goodwill
Cytek Biosciences, Inc. Goodwill History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$16.7M
FY2025
5-year range
$10.1M / $16.7M
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#123 of 136
Health Care
What the data says
Among 136 Health Care companies, Cytek Biosciences, Inc. is in the bottom 10% for goodwill. Goodwill has increased for 3 consecutive years, from $10M in FY2022 to $17M in FY2025.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of +103.7%.
Improved from $16M to $17M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +18.1%
- 5-Year CAGR
- +103.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 136This company $16.7M Sector average $5.2B
▼
-99.7% below sector average
Key checks
Key Insights
- Cytek Biosciences, Inc.'s goodwill has grown for 3 consecutive years.
- 5-year CAGR of +103.7%, indicating consistent growth.
- In FY2025, goodwill increased 0.2% year-over-year.
- Ranks #123 out of 136 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.7M | +0.2% |
| FY2024 | $16.7M | +3.0% |
| FY2023 | $16.2M | +59.5% |
| FY2022 | $10.1M | +0.0% |
| FY2021 | $10.1M | +2031.1% |
| FY2020 | $476.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026